About: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.05 (-1.12%)
SERA NASDAQ Sera Prognostics Inc
Sera Prognostics Inc share price
SERA price activity
Last Price
$2.050
Change (24hr)
-0.02 USD (-1.12%)
Volume
1.37K
Volume (4w avg)
-
Open
$2.03
Day Range
$2.03 - $2.05
Previous Close
$2.07
Last Trade
13 Oct, 3:43 pm GMT+0
Delayed
13 Oct, 3:43 pm GMT+0
SERA price performance
Delayed
13 Oct, 3:43 pm GMT+0
SERA Market Signals